AU2006304640B2 - Functional influenza virus like particles (VLPs) - Google Patents

Functional influenza virus like particles (VLPs) Download PDF

Info

Publication number
AU2006304640B2
AU2006304640B2 AU2006304640A AU2006304640A AU2006304640B2 AU 2006304640 B2 AU2006304640 B2 AU 2006304640B2 AU 2006304640 A AU2006304640 A AU 2006304640A AU 2006304640 A AU2006304640 A AU 2006304640A AU 2006304640 B2 AU2006304640 B2 AU 2006304640B2
Authority
AU
Australia
Prior art keywords
influenza
vlp
proteins
vlps
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2006304640A
Other languages
English (en)
Other versions
AU2006304640A1 (en
Inventor
Rick Bright
Kutub Mahmood
Peter Pushko
Gale Smith
Jinyou Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novavax Inc
Original Assignee
Novavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novavax Inc filed Critical Novavax Inc
Publication of AU2006304640A1 publication Critical patent/AU2006304640A1/en
Application granted granted Critical
Publication of AU2006304640B2 publication Critical patent/AU2006304640B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2006304640A 2005-10-18 2006-10-18 Functional influenza virus like particles (VLPs) Active AU2006304640B2 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US72751305P 2005-10-18 2005-10-18
US60/727,513 2005-10-18
US78084706P 2006-03-10 2006-03-10
US60/780,847 2006-03-10
US80000606P 2006-05-15 2006-05-15
US60/800,006 2006-05-15
US83119606P 2006-07-17 2006-07-17
US60/831,196 2006-07-17
US83211606P 2006-07-21 2006-07-21
US60/832,116 2006-07-21
US84549506P 2006-09-19 2006-09-19
US60/845,495 2006-09-19
PCT/US2006/040862 WO2007047831A2 (en) 2005-10-18 2006-10-18 Functional influenza virus like particles (vlps)

Publications (2)

Publication Number Publication Date
AU2006304640A1 AU2006304640A1 (en) 2007-04-26
AU2006304640B2 true AU2006304640B2 (en) 2012-10-11

Family

ID=37963272

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006304640A Active AU2006304640B2 (en) 2005-10-18 2006-10-18 Functional influenza virus like particles (VLPs)

Country Status (19)

Country Link
EP (1) EP1937301B1 (enExample)
JP (5) JP5714799B2 (enExample)
KR (1) KR101359723B1 (enExample)
CN (2) CN103865892B (enExample)
AU (1) AU2006304640B2 (enExample)
BR (1) BRPI0617486A2 (enExample)
CA (1) CA2625406C (enExample)
DK (1) DK1937301T3 (enExample)
ES (1) ES2543056T3 (enExample)
HU (1) HUE026136T2 (enExample)
IL (1) IL190775A (enExample)
NZ (1) NZ567164A (enExample)
PL (1) PL1937301T3 (enExample)
PT (1) PT1937301E (enExample)
RU (1) RU2483751C2 (enExample)
SG (1) SG2014012868A (enExample)
SI (1) SI1937301T1 (enExample)
TW (1) TWI488968B (enExample)
WO (1) WO2007047831A2 (enExample)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0250488A (ja) * 1988-08-11 1990-02-20 Nec Corp 超伝導配線
US8551756B2 (en) 2003-07-11 2013-10-08 Novavax, Inc. Avian influenza chimeric VLPS
WO2007130327A2 (en) 2006-05-01 2007-11-15 Technovax, Inc. Influenza virus-like particle (vlp) compositions
US9101578B2 (en) 2006-05-01 2015-08-11 Technovax, Inc. Polyvalent influenza virus-like particle (VLP) compositions
AU2007345768B2 (en) * 2006-07-27 2013-08-01 Ligocyte Pharmaceuticals, Inc. Chimeric influenza virus-like particles
US8202967B2 (en) 2006-10-27 2012-06-19 Boehringer Ingelheim Vetmedica, Inc. H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
CA2615372A1 (en) * 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
JP2010533737A (ja) * 2007-07-19 2010-10-28 ノババックス，インコーポレイテッド キメラ水痘帯状疱疹ウイルス−ウイルス様粒子
AU2008331673B2 (en) * 2007-11-12 2014-12-11 The Trustees Of The University Of Pennsylvania Novel vaccines against multiple subtypes of influenza virus
KR20100120157A (ko) 2007-11-27 2010-11-12 메디카고 인코포레이티드 헤마글루티닌을 발현하는 트랜스제닉 식물에서 생산된 재조합 인플루엔자 바이러스-유사 입자(ＶＬＰｓ)
EP2294202B1 (en) 2008-07-08 2015-05-20 Medicago Inc. Soluble recombinant influenza antigens
DK2318530T3 (en) * 2008-07-18 2016-10-03 Medicago Inc Ny epitope to immunization against influenza
US8394384B2 (en) * 2008-11-28 2013-03-12 Merial Limited Recombinant avian influenza vaccine and uses thereof
AU2010243490A1 (en) * 2009-04-30 2011-11-24 Cytos Biotechnology Ag Influenza hemagglutinin compositions and uses thereof
EP2952581A1 (en) * 2009-05-01 2015-12-09 Redbiotec AG Recombinant virus-like particles encoded by multi-gene vector
TW201738562A (zh) * 2009-05-28 2017-11-01 亞培生物股份有限公司 體外病原體檢驗技術
HRP20180706T1 (hr) 2009-06-24 2018-06-01 Medicago Inc. Kimerna gripa nalik čestici koja sadrži hemaglutinin
CN102549148A (zh) 2009-09-22 2012-07-04 麦迪卡格公司 制备植物来源的vlp的方法
EP2536428B1 (en) * 2010-02-18 2018-12-05 Technovax, Inc. Universal virus-like particle (vlp) influenza vaccines
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
JP2012036154A (ja) * 2010-08-11 2012-02-23 Goshu Yakuhin Kk 食品
CN101947317B (zh) * 2010-09-27 2012-05-30 武汉大学 一种h5n1禽流感病毒样颗粒疫苗的规模化制备方法
CN102676461A (zh) * 2011-03-17 2012-09-19 中国科学院上海巴斯德研究所 一种利用果蝇细胞生产病毒样颗粒的方法及应用
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
EA016866B1 (ru) * 2011-06-06 2012-08-30 Общество С Ограниченной Ответственностью "Форт" (Ооо "Форт") Вакцина для специфической профилактики гриппа
KR101302245B1 (ko) * 2011-06-27 2013-09-02 조지아 스테이트 유니버시티 리서치 파운데이션, 인코포레이티드 넓은 범위의 교차 방어능력을 갖는 신규한 보강 인플루엔자 백신
AR088028A1 (es) 2011-08-15 2014-05-07 Boehringer Ingelheim Vetmed Proteinas h5, de h5n1 para un uso medicinal
JP2014527799A (ja) 2011-08-26 2014-10-23 ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション 変異型ｐｂ２遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス
JP5884100B2 (ja) * 2011-08-31 2016-03-15 公益財団法人東京都医学総合研究所 新型インフルエンザウイルス由来ヘマグルチニンタンパク質遺伝子を有するＤＩｓ株由来組換えワクシニアウイルス
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
TWI700368B (zh) 2011-09-30 2020-08-01 苜蓿股份有限公司 增加植物類病毒顆粒產率
CA2863658C (en) * 2012-02-03 2023-03-14 Emory University Immunostimulatory compositions, particles, and uses related thereto
RU2485973C1 (ru) * 2012-02-28 2013-06-27 Общество с ограниченной ответственностью "НТфарма" Рекомбинантная трехвалентная вакцина от гриппа человека
EP2958586B1 (en) * 2013-02-21 2018-09-05 Boehringer Ingelheim Vetmedica GmbH H5 proteins of h5n1 influenza virus for use as a medicament
US9649375B2 (en) * 2013-03-14 2017-05-16 The Administrators Of The Tulane Educational Fund Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith
IL295155A (en) 2013-03-28 2022-09-01 Medicago Inc Production of influenza virus-like particles in plants
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
TWI714522B (zh) 2014-01-10 2021-01-01 加拿大商苜蓿股份有限公司 Cpmv強化子元件
CN103740655A (zh) * 2014-01-20 2014-04-23 瑞鑫百奥生物科技（深圳）有限公司 H5n1禽流感病毒样颗粒及其应用和制备方法、疫苗
AU2015234595B2 (en) 2014-03-27 2021-03-25 Medicago Inc. Modified CPMV enhancer elements
US10053671B2 (en) 2014-06-20 2018-08-21 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
CN106559986A (zh) * 2014-06-20 2017-04-05 美国政府(由卫生和人类服务部的部长所代表) 多价流感病毒样颗粒(vlp)及其作为疫苗的用途
JP2018530314A (ja) * 2015-08-28 2018-10-18 ウィスコンシン アルムニ リサーチ ファンデイション ウイルス様粒子からの感染性インフルエンザウイルスの生成
RU2639491C2 (ru) * 2015-08-31 2017-12-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Вирионы и вирусоподобные частицы вируса мозаики альтернантеры как усилители иммунного ответа
EP3344291B1 (en) 2015-09-03 2024-11-27 Novavax, Inc. Vaccine compositions having improved stability and immunogenicity
CA3014435C (en) 2016-02-19 2023-04-18 Wisconsin Alumni Research Foundation (Warf) Improved influenza b virus replication for vaccine development
WO2017184626A1 (en) * 2016-04-18 2017-10-26 Emerging Viral Vaccine Limited Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery
US12214052B2 (en) 2017-08-04 2025-02-04 The Hospital For Sick Children Nanoparticle platform for antibody and vaccine delivery
CN107353328A (zh) * 2017-08-23 2017-11-17 上海市动物疫病预防控制中心 一种重组的h9n2亚型禽流感病毒样颗粒及其制备方法和用途
CN110240634B (zh) * 2018-03-08 2022-09-06 普莱柯生物工程股份有限公司 一种禽流感病毒样颗粒疫苗、及其制备方法和应用
CN108409842A (zh) * 2018-03-15 2018-08-17 山东省农业科学院畜牧兽医研究所 一种单克隆抗体及其制备方法
WO2020033527A2 (en) 2018-08-07 2020-02-13 Wisconsin Alumni Research Foundation (Warf) Recombinant biologically contained filovirus vaccine
JP7655849B2 (ja) 2018-08-20 2025-04-02 ウィスコンシン アルムニ リサーチ ファンデイション ヘマグルチニン（ｈａ）タンパク質内の非ドミナントエピトープに対する免疫応答を誘起するためのベクター
WO2020163804A1 (en) 2019-02-08 2020-08-13 Wisconsin Alumni Research Foundation (Warf) Humanized cell line
US11390649B2 (en) 2019-05-01 2022-07-19 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication for vaccine development
US11807872B2 (en) 2019-08-27 2023-11-07 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized HA for replication in eggs
US11739303B2 (en) 2020-01-24 2023-08-29 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized NA
BR112022018160A2 (pt) * 2020-03-24 2022-10-25 Byung Chul Ahn Método de produção de composição de soro para prevenir ou tratar doenças infecciosas relacionadas à mucosa em mamíferos jovens, composição de soro produzida por ele, e uso da mesma
KR102151962B1 (ko) * 2020-03-24 2020-09-04 안병철 어린 포유동물의 전염성 질병을 예방 또는 치료하기 위한 혈청 조성물의 제조방법, 상기 방법에 의해 제조된 혈청 조성물 및 이의 용도
US12290562B2 (en) 2020-03-25 2025-05-06 Wisconsin Alumni Research Foundation (Warf) Recombinant multivalent influenza viruses
CN113461786B (zh) * 2020-03-30 2022-09-13 普莱柯生物工程股份有限公司 一种禽流感病毒样颗粒疫苗、及其制备方法和应用
AU2021262999A1 (en) 2020-05-01 2023-01-19 Sinocelltech Ltd. Method for improving immunogenicity of protein/peptide antigen
CN112342149A (zh) * 2020-11-12 2021-02-09 新疆畜牧科学院兽医研究所（新疆畜牧科学院动物临床医学研究中心） 一种禽流感病毒样颗粒组装表达系统及其应用
CN112979796A (zh) * 2021-04-27 2021-06-18 军事科学院军事医学研究院军事兽医研究所 马抗甲型h5n1虎源流感病毒免疫球蛋白和特异性免疫球蛋白及其精制方法
CN113862284B (zh) * 2021-09-13 2023-05-26 华南农业大学 一种编码重组禽流感病毒ha蛋白的基因、病毒样颗粒、疫苗及制备与应用
CN114262720B (zh) * 2021-12-27 2023-07-25 河南兴华生物技术有限公司 杆状病毒表达系统的信号肽及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000885A2 (en) * 2000-06-23 2002-01-03 American Cyanamid Company Assembly of wild-type and chimeric influenza virus-like particles (vlps)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866034A (en) 1982-05-26 1989-09-12 Ribi Immunochem Research Inc. Refined detoxified endotoxin
US4877611A (en) 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4911928A (en) 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US6387373B1 (en) 1993-01-15 2002-05-14 Novavax, Inc. Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants
US5629021A (en) 1995-01-31 1997-05-13 Novavax, Inc. Micellar nanoparticles
WO2003068804A2 (en) 2002-02-14 2003-08-21 Novavax, Inc. Novel insect cell line
US8592197B2 (en) * 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000885A2 (en) * 2000-06-23 2002-01-03 American Cyanamid Company Assembly of wild-type and chimeric influenza virus-like particles (vlps)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LATHAM T. ET AL. 2001 J. Virol. vol. 75, no. 13, pp. 6154-6165 *
WOOD J.M. ET AL. 2002 Vaccine vol. 20, no. suppl. 2, pp. S84 - S87 *

Also Published As

Publication number Publication date
TWI488968B (zh) 2015-06-21
CA2625406A1 (en) 2007-04-26
AU2006304640A1 (en) 2007-04-26
JP2017189178A (ja) 2017-10-19
TW200732476A (en) 2007-09-01
KR101359723B1 (ko) 2014-02-05
JP2016135142A (ja) 2016-07-28
CN103865892B (zh) 2017-04-12
HUE026136T2 (en) 2016-05-30
WO2007047831A3 (en) 2007-07-19
ES2543056T3 (es) 2015-08-14
JP2015083018A (ja) 2015-04-30
CN101325966B (zh) 2014-04-09
SG2014012868A (en) 2014-09-26
SI1937301T1 (sl) 2015-08-31
DK1937301T3 (en) 2015-07-20
EP1937301B1 (en) 2015-04-22
CN101325966A (zh) 2008-12-17
EP1937301A2 (en) 2008-07-02
NZ567164A (en) 2012-06-29
IL190775A (en) 2016-04-21
KR20080081901A (ko) 2008-09-10
CA2625406C (en) 2016-08-09
RU2008119501A (ru) 2009-11-27
RU2483751C2 (ru) 2013-06-10
JP5714799B2 (ja) 2015-05-07
IL190775A0 (en) 2008-11-03
PT1937301E (pt) 2015-09-14
PL1937301T3 (pl) 2015-10-30
HK1121687A1 (en) 2009-04-30
JP5771558B2 (ja) 2015-09-02
JP2012157367A (ja) 2012-08-23
CN103865892A (zh) 2014-06-18
EP1937301A4 (en) 2009-06-24
WO2007047831A2 (en) 2007-04-26
JP2009511084A (ja) 2009-03-19
BRPI0617486A2 (pt) 2011-07-26

Similar Documents

Publication Publication Date Title
US10548968B2 (en) Functional influenza virus-like particles (VLPS)
US10729760B2 (en) Functional influenza virus like particles (VLPs)
AU2006304640B2 (en) Functional influenza virus like particles (VLPs)
US10544399B2 (en) Highly efficient influenza matrix (M1) proteins
HK1121687B (en) Functional influenza virus like particles (vlps)
HK1194099A (en) Functional influenza virus like particles (vlps)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)